NOVO REAL-WORLD STUDIES LINK WEGOVY® 2.4 MG TO REDUCTIONS IN LIVER ENZYMES, WEIGHT, AND BLOOD SUGAR IN ADULTS WITH MASH AT THE LIVER MEETING® (AASLD) 2026

Reuters · 1d ago

Please log in to view news